MSHO Featured Corporate Sponsor Assistance Program
TerSera is committed to help remove the financial and access barriers that so often get in the way of patients who are prescribed ZOLADEX® (goserelin acetate implant) and VARUBI® (rolapitant) tablets.
To learn more, click here.
MSHO will profile a different Corporate Sponsor Assistance Program in each Bulletin. To view more Patient Assistance Programs, click here.
Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!